Dr. Thiravat Hemachudha, Professor of Neurology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, posted on Facebook. Thiravat Hemachudha The report’s data, released through late April 2024, reinforce the link between mRNA vaccines and statistically significant increases in mortality across all cancers, particularly estrogen-related cancers, following the third dose.
“Dr. Thirawat” raises a case of side effects and abnormalities after injecting AstraZeneca-mRNA
CDC recommends COVID-19 and flu vaccinations to reduce complications and mortality
A report from Japan on April 8, 2024, in the Nature journal Cureus.
This report assesses the impact of the COVID-19 outbreak in Japan. It analyzes the mortality rates of 20 types of cancer in Japan using official data related to death, COVID-19 infection, and COVID-19 vaccination, adjusting for different age groups (age adjusted mortality).
The results are a startling discovery: during the first year of the COVID-19 pandemic, there was no excess cancer deaths, but deaths increased in line with COVID-19 vaccination.
Japan has the highest vaccination rate and is set to administer its seventh dose of COVID-19 in 2024.
The nationwide vaccination drive began in 2021, and cancer deaths began to rise alongside the first and second doses of the vaccine.
After the third dose in 2022, there were abnormal cancer deaths in all cancers and especially in estrogen and estrogen receptor alpha (ERalpha)-sensitive cancers. This includes ovarian cancer, leukemia, prostate cancer, lip cancer, oral cancer, throat cancer, pancreatic cancer, and breast cancer.
For breast cancer, there was a decrease in breast cancer mortality in 2020, but then it changed to a significant increase in 2022 with the nationwide rollout of the third dose of the vaccine.
Pancreatic cancer had been on a steady upward trend prior to the COVID pandemic, and five other cancers were on a downward trend. However, six cancers still had higher-than-expected mortality in 2021, 2022, and both periods.
Moreover, four cancers that were already highly lethal – lung, colorectal, stomach and liver – had seen mortality declines prior to 2020, but mortality did not decline as much as before the start of the vaccine rollout.
Cancer mortality rates surged even before the COVID-19 pandemic. In Japan, cancer mortality showed a downward trend at all ages, except those aged 90 and over.
And even in 2020, before the vaccines were ramped up and COVID hit, cancer mortality rates were still falling across almost every age group except those aged 75 to 79.
- In 2021, we began to see a trend of higher and continuing higher cancer mortality rates through 2022 across all age groups.
- In 2021, there was a significant increase in all-cause mortality of 2.1% and 1.1% for cancer mortality.
- In 2022, all-cause mortality jumped to 9.6% and for cancer, it jumped to 2.1%.
The study broke down by age and found that all-cause mortality peaked in the 80-84 age group, when more than 90% of the population had received three doses of the vaccine, and nearly 100% of the vaccines received were mRNA, with Pfizer (78%) and Moderna (22%).
The rapporteurs also focused on the possibility that the rise in cancer deaths could be due to less screening and limited access to treatment during the lockdowns, but said they could not explain the jump in deaths specifically for six cancers in 2022, when screening and treatment restrictions were lifted.
And the cancers with higher mortality rates are those that are ERalpha-sensitive, which could be explained by multiple mechanisms of the mRNA vaccine being housed in lipid nanoparticles, rather than by COVID infection or reduced treatment during the lockdown.
“The report clearly points to epidemiological data linking higher mortality rates for several cancers to multiple doses of vaccine,” said MIT senior research scientist Stephanie Seneff.
This is because, as previously stated, based on the basic scientific mechanisms of the immune system, vaccines should be related to the occurrence of cancer, where vaccines cause the system for monitoring and preventing cancer to decline, especially in the system called innate immunity, and defects in the immune chain that lead to easier infection and more autoimmune diseases that damage oneself, and cause cancer to grow and spread quickly.
